Skip to main content
Clinical Trials/CTRI/2023/03/050390
CTRI/2023/03/050390Not yet recruitingUnknown

The Effect of Preoperative IV Tranexamic acid on intraoperative blood loss in cancer surgeries at a tertiary care centre in South India â?? A Randomised Controlled Trial

nil0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • all cancer patients undergoing surgeries for breast gyanecology, Head &neck ,GI, soft tissue sarcoma& others

Exclusion Criteria

  • Patients with coagulopathy(activated partial thromboplastin time >50 s or International normalised ratio >1.5, platelets <50 X 109/L), Recent history of acetylsalicylic acid ingestion ( < 5 days), Patients on anticoagulation therapy (received heparin within 4 hours or received warfarin 3 days preoperatively), Those with known peripheral vascular disease, Pre-existing renal dysfunction (serum creatinine >1.2 mg/dl), Liver dysfunction, Known allergy to tranexamic acid

Investigators

Sponsor
nil

Similar Trials